Here are the studies that match your search criteria. If you are interested in participating, please reach out to the contact listed for the study. If no contact is listed, contact us and we'll help you find the right person.
1
Study Matches
NMTT- Neuroblastoma Maintenance Therapy Trial Using Difluoromethylornithine (DFMO)
A study of DFMO for patients with neuroblastoma in remission.
A confirmed diagnosis of neuroblastoma. Must be in complete remission (CR). Tests and scans will be required to confirm remission.
Exclusion Criteria:
Patients below the defined minimum of height and weight. Patients who are currently receiving another study drug may not participate. Patients who are currently receiving other anticancer agents may not participate.